2 results for "immunotherapy"
Melanoma metastasis risk peaks in middle age and drops in old age, study finds. A specific immune cell keeps cancer dormant. Discover actionable protocols to bo
ASCO 2026 study shows low-dose nivolumab extends survival in head and neck cancer, offering a path to affordable immunotherapy in low-resource settings.
